SPRT near to strong weekly support level. possibly buy. wait for confirmation. I cant believe the Food and Drug Administration rejected the latest Duchenne muscular dystrophy drug, dubbed golodirsen. This could get ugly. Watching for a bounce and keeping an eye on the overall market as well. also watching this one.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.